Effects of the 5-HT2C/2B antagonist SB 206553 on hyperactivity induced by cocaine

被引:74
|
作者
McCreary, AC [1 ]
Cunningham, KA [1 ]
机构
[1] Univ Texas, Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA
关键词
cocaine; hyperactivity; SB; 206553; serotonin; 5-HT2C; 5-HT2B;
D O I
10.1016/S0893-133X(98)00087-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Serotonin (5-HT) appears to play a modulatory role in the behavioral effects of cocaine, although the impact of 5-HT2C receptors in this control has not been fully established. The aim of the present study was to establish whether acute pretreatment with the selective 5-HT2C/2B antagonist SB 206553 (1, 2, and 4 mg/kg IP) altered hyperactivity induced by cocaine (15 mg/kg, IP) using an open field activity system which recorded central, peripheral, and rearing activity. Pretreatment with 1 and 2 mg/kg of SB 206553 attenuated cocaine-induced central and peripheral activity, respectively; rearing was also attenuated by the latter dose. However, the 4-mg/kg dose of SB 206553 significantly enhanced the effects of cocaine on peripheral activity. Based upon the present observations and an interpretation of previous research to implicate 5-HT2C receptor control of the dopamine (DA) mesoaccumbens pathways in behavior, a thorough and systematic analysis of the role of 5-HT2C (and 5-HT2B) receptors in psychostimulant-induced behaviors is warranted. (C) 1999 American College of Neuropsychopharmacology. Published by Elsevier Science Inc.
引用
收藏
页码:556 / 564
页数:9
相关论文
共 50 条
  • [1] Effects of the 5-HT2C/2B Antagonist SB 206553 on Hyperactivity Induced by Cocaine
    Andrew C McCreary
    Kathryn A Cunningham
    Neuropsychopharmacology, 1999, 20 : 556 - 564
  • [2] IN-VIVO PROPERTIES OF SB 200646A, A 5-HT2C/2B RECEPTOR ANTAGONIST
    KENNETT, GA
    WOOD, MD
    GLEN, A
    GREWAL, S
    FORBES, I
    GADRE, A
    BLACKBURN, TP
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 111 (03) : 797 - 802
  • [3] SB 206553, a putative 5-HT2C inverse agonist, attenuates methamphetamine-seeking in rats
    Graves, Steven M.
    Napier, T. Celeste
    BMC NEUROSCIENCE, 2012, 13
  • [4] SB 242084:: A selective 5-HT2C receptor antagonist
    Di Matteo, V
    Di Giovanni, G
    Esposito, E
    CNS DRUG REVIEWS, 2000, 6 (03): : 195 - 205
  • [5] Differential effects of the 5-HT2A receptor antagonist M100,907 and the 5-HT2C receptor antagonist SB242,084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding
    Fletcher P.J.
    Grottick A.J.
    Higgins G.A.
    Neuropsychopharmacology, 2002, 27 (4) : 576 - 586
  • [6] Differential effects of the 5-HT2A receptor antagonist M100,907 and the 5-HT2C receptor antagonist SB242,084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding
    Fletcher, PJ
    Grottick, AJ
    Higgins, GA
    NEUROPSYCHOPHARMACOLOGY, 2002, 27 (04) : 576 - 586
  • [7] Individual differences in the improvement of cocaine-induced place preference response by the 5-HT2C receptor antagonist SB242084 in rats
    Capriles, Nancy
    Watson, Stanley, Jr.
    Akil, Huda
    PSYCHOPHARMACOLOGY, 2012, 220 (04) : 731 - 740
  • [8] SB 206553, a putative 5-HT2C inverse agonist, attenuates methamphetamine-seeking in rats
    Steven M Graves
    T Celeste Napier
    BMC Neuroscience, 13
  • [9] EFFECT OF SB 200646A, A 5-HT2C 5-HT2B RECEPTOR ANTAGONIST, IN 2 CONFLICT MODELS OF ANXIETY
    KENNETT, GA
    BAILEY, F
    PIPER, DC
    BLACKBURN, TP
    PSYCHOPHARMACOLOGY, 1995, 118 (02) : 178 - 182
  • [10] SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist
    Kennett, GA
    Wood, MD
    Bright, F
    Trail, B
    Riley, G
    Holland, V
    Avenell, KY
    Stean, T
    Upton, N
    Bromidge, S
    Forbes, IT
    Brown, AM
    Middlemiss, DN
    Blackburn, TP
    NEUROPHARMACOLOGY, 1997, 36 (4-5) : 609 - 620